English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/232595
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Targeting Lipid Peroxidation for Cancer Treatment

AuthorsClemente, Sofia M.; Martínez-Costa, Oscar H. ; Monsalve, María ; Samhan-Arias, Alejandro K.
KeywordsCancer
Peroxides
LOX
COX
Fenton reaction
Iron
Ferroptosis
Nanoparticles
Issue Date2020
PublisherMultidisciplinary Digital Publishing Institute
CitationMolecules 25(21): 5144 (2020)
AbstractCancer is one of the highest prevalent diseases in humans. The chances of surviving cancer and its prognosis are very dependent on the affected tissue, body location, and stage at which the disease is diagnosed. Researchers and pharmaceutical companies worldwide are pursuing many attempts to look for compounds to treat this malignancy. Most of the current strategies to fight cancer implicate the use of compounds acting on DNA damage checkpoints, non-receptor tyrosine kinases activities, regulators of the hedgehog signaling pathways, and metabolic adaptations placed in cancer. In the last decade, the finding of a lipid peroxidation increase linked to 15-lipoxygenases isoform 1 (15-LOX-1) activity stimulation has been found in specific successful treatments against cancer. This discovery contrasts with the production of other lipid oxidation signatures generated by stimulation of other lipoxygenases such as 5-LOX and 12-LOX, and cyclooxygenase (COX-2) activities, which have been suggested as cancer biomarkers and which inhibitors present anti-tumoral and antiproliferative activities. These findings support the previously proposed role of lipid hydroperoxides and their metabolites as cancer cell mediators. Depletion or promotion of lipid peroxidation is generally related to a specific production source associated with a cancer stage or tissue in which cancer originates. This review highlights the potential therapeutical use of chemical derivatives to stimulate or block specific cellular routes to generate lipid hydroperoxides to treat this disease.
Description© 2020 by the authors.
Publisher version (URL)http://dx.doi.org/10.3390/molecules25215144
URIhttp://hdl.handle.net/10261/232595
DOIhttp://dx.doi.org/10.3390/molecules25215144
E-ISSN1420-3049
Appears in Collections:(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
Targeting_Clemente_PV_Art2020.pdf2 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.